Our Neurological Institute paired cultural changes with visual schedule boards and frequent team huddles to drive ongoing improvement in operating room scheduling. This case study shares details and results.
Will we fight neurodegenerative diseases the way we robustly took on HIV/AIDS — or with the limited attention we’ve devoted to combating malaria?
The team conducting the first-in-human clinical trial of deep brain stimulation for stroke recovery garnered $2.5M to continue parallel preclinical studies of the underlying mechanisms.
An information-guided approach to care — involving brain mapping, image post-processing and more — is leading to enhanced diagnosis and more-personalized treatments in patients with complex neurological diseases.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
DBS-induced changes on magnetoencephalography reflect treatment effects and could serve as biomarkers for treatment efficacy.
It’s awfully easy for caregivers to forget to take care of themselves. Andre Machado, MD, shares his eye-opening experience having his first physical through Cleveland Clinic’s Executive Health Program at age 40.
Here’s a status update from this historic trial, including a rundown of elements being investigated in addition to stroke survivors’ functional outcomes.
Functional improvements have not yet plateaued after four months of rehabilitative therapy plus deep brain stimulation (DBS) in the first patient to ever undergo DBS to restore motor function after stroke.
The first-in-human trial of neuromodulation for rehabilitative therapy in stroke survivors has been given a boost with a $5 million grant. The lead investigator explains the study’s goals and rationale.
Cleveland Clinic announces it’s ready to start enrollment in a pioneering trial of deep brain stimulation following official clearance from the FDA.